Literature DB >> 24194479

S100B as a marker for brain damage and blood-brain barrier disruption following exercise.

Serene X T Koh1, Jason K W Lee.   

Abstract

BACKGROUND: S100B level in the blood has been used as a marker for brain damage and blood-brain barrier (BBB) disruption. Elevations of S100B levels after exercise have been observed, suggesting that the BBB may be compromised during exercise. However, an increase in S100B levels may be confounded by other variables.
OBJECTIVES: The primary objective of this review was to compile findings on the relationship between S100B and exercise in order to determine if this protein is a valid marker for BBB disruptions during exercise. The secondary objective was to consolidate known factors causing S100B increases that may give rise to inaccurate interpretations of S100B levels. DATA SOURCES AND STUDY SELECTION: PubMed, Web of Science and ScienceDirect were searched for relevant studies up to January 2013, in which S100B measurements were taken after a bout of exercise. Animal studies were excluded. Variables of interest such as the type of activity, exercise intensities, duration, detection methods, presence and extent of head trauma were examined and compiled.
RESULTS: This review included 23 studies; 15 (65 %) reported S100B increases after exercise, and among these, ten reported S100B increases regardless of intervention, while five reported increases in only some trials but not others. Eight (35 %) studies reported no increases in S100B levels across all trials. Most baseline S100B levels fall below 0.16 μg/L, with an increase in S100B levels of less than 0.07 μg/L following exercise. Factors that are likely to affect S100B levels include exercise intensity, and duration, presence and extent of head trauma. Several other probable factors influencing S100B elevations are muscle breakdown, level of training and oxidative stress, but current findings are still weak and inconclusive.
CONCLUSIONS: Elevated S100B levels have been recorded following exercise and are mostly attributed to either an increase in BBB permeability or trauma to the head. However, even in the absence of head trauma, it appears that the BBB may be compromised following exercise, with the severity dependent on exercise intensity.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24194479     DOI: 10.1007/s40279-013-0119-9

Source DB:  PubMed          Journal:  Sports Med        ISSN: 0112-1642            Impact factor:   11.136


  109 in total

1.  Effects of head and extracranial injuries on serum protein S100B levels in trauma patients.

Authors:  Olli Savola; Juhani Pyhtinen; Tuomo K Leino; Simo Siitonen; Onni Niemelä; Matti Hillbom
Journal:  J Trauma       Date:  2004-06

2.  S100B profiles and cognitive function at high altitude.

Authors:  Henrik Bjursten; Per Ederoth; Engilbert Sigurdsson; Magnus Gottfredsson; Ingvar Syk; Orri Einarsson; Tomas Gudbjartsson
Journal:  High Alt Med Biol       Date:  2010       Impact factor: 1.981

3.  Neurotrophic activity of S-100 beta in cultures of dorsal root ganglia from embryonic chick and fetal rat.

Authors:  L J Van Eldik; B Christie-Pope; L M Bolin; E M Shooter; W O Whetsell
Journal:  Brain Res       Date:  1991-03-01       Impact factor: 3.252

4.  Effects of mode of delivery on maternal-neonatal plasma antioxidant status and on protein S100B serum concentrations.

Authors:  K H Schulpis; A Margeli; A Akalestos; G D Vlachos; G A Partsinevelos; M Papastamataki; A Antsaklis; I Papassotiriou
Journal:  Scand J Clin Lab Invest       Date:  2006       Impact factor: 1.713

5.  Correlation of astrocytic S100 beta expression with dystrophic neurites in amyloid plaques of Alzheimer's disease.

Authors:  R E Mrak; J G Sheng; W S Griffin
Journal:  J Neuropathol Exp Neurol       Date:  1996-03       Impact factor: 3.685

6.  From catastrophe to complexity: a novel model of integrative central neural regulation of effort and fatigue during exercise in humans: summary and conclusions.

Authors:  T D Noakes; A St Clair Gibson; E V Lambert
Journal:  Br J Sports Med       Date:  2005-02       Impact factor: 13.800

7.  Cerebrospinal fluid S100B is elevated in the earlier stages of Alzheimer's disease.

Authors:  E R Peskind; W S Griffin; K T Akama; M A Raskind; L J Van Eldik
Journal:  Neurochem Int       Date:  2001 Nov-Dec       Impact factor: 3.921

8.  Serum S-100beta as a possible marker of blood-brain barrier disruption.

Authors:  M Kapural; Lj Krizanac-Bengez; G Barnett; J Perl; T Masaryk; D Apollo; P Rasmussen; M R Mayberg; D Janigro
Journal:  Brain Res       Date:  2002-06-14       Impact factor: 3.252

9.  Increased serum S100B in never-medicated and medicated schizophrenic patients.

Authors:  Xiang Yang Zhang; Mei Hong Xiu; Cai Song; Da Chun Chen; Gui Ying Wu; Colin N Haile; Therese A Kosten; Thomas R Kosten
Journal:  J Psychiatr Res       Date:  2010-05-26       Impact factor: 4.791

10.  Serum concentrations of two biochemical markers of brain tissue damage S-100B and neurone specific enolase are increased in elite female soccer players after a competitive game.

Authors:  B-M Stålnacke; A Ohlsson; Y Tegner; P Sojka
Journal:  Br J Sports Med       Date:  2006-04       Impact factor: 13.800

View more
  44 in total

1.  S100B blood levels and childhood trauma in adolescent inpatients.

Authors:  Tatiana Falcone; Damir Janigro; Rachel Lovell; Barry Simon; Charles A Brown; Mariela Herrera; Aye Mu Myint; Amit Anand
Journal:  J Psychiatr Res       Date:  2014-12-25       Impact factor: 4.791

Review 2.  The Potential Mechanisms of Exercise-induced Cognitive Protection: A Literature Review.

Authors:  Jennifer E Norman; Jennifer Rutkowsky; Sue Bodine; John C Rutledge
Journal:  Curr Pharm Des       Date:  2018       Impact factor: 3.116

Review 3.  Current status of fluid biomarkers in mild traumatic brain injury.

Authors:  Jacqueline R Kulbe; James W Geddes
Journal:  Exp Neurol       Date:  2015-05-14       Impact factor: 5.330

4.  Cerebral blood flow, frontal lobe oxygenation and intra-arterial blood pressure during sprint exercise in normoxia and severe acute hypoxia in humans.

Authors:  David Curtelin; David Morales-Alamo; Rafael Torres-Peralta; Peter Rasmussen; Marcos Martin-Rincon; Mario Perez-Valera; Christoph Siebenmann; Ismael Pérez-Suárez; Evgenia Cherouveim; A William Sheel; Carsten Lundby; José Al Calbet
Journal:  J Cereb Blood Flow Metab       Date:  2017-02-10       Impact factor: 6.200

5.  S100B as a Potential Biomarker and Therapeutic Target in Multiple Sclerosis.

Authors:  Andreia Barateiro; Vera Afonso; Gisela Santos; João José Cerqueira; Dora Brites; Jack van Horssen; Adelaide Fernandes
Journal:  Mol Neurobiol       Date:  2015-07-17       Impact factor: 5.590

6.  FEASibility testing a randomized controlled trial of an exercise program to improve cognition for T2DM patients (the FEAST trial): A study protocol.

Authors:  Tingting Liu; Lindsey Hettish; Wen-Juo Lo; Michelle Gray; Changwei Li
Journal:  Res Nurs Health       Date:  2021-08-16       Impact factor: 2.238

7.  High-intensity interval training modulates inflammatory response in Parkinson's disease.

Authors:  Paulina Malczynska-Sims; Małgorzata Chalimoniuk; Zbigniew Wronski; Jaroslaw Marusiak; Anna Sulek
Journal:  Aging Clin Exp Res       Date:  2022-06-14       Impact factor: 4.481

Review 8.  Biomarkers of Epileptogenesis: The Focus on Glia and Cognitive Dysfunctions.

Authors:  Annamaria Vezzani; Rosaria Pascente; Teresa Ravizza
Journal:  Neurochem Res       Date:  2017-04-22       Impact factor: 3.996

9.  High S100B Levels Predict Antidepressant Response in Patients With Major Depression Even When Considering Inflammatory and Metabolic Markers.

Authors:  Ricard Navinés; Giovanni Oriolo; Igor Horrillo; Myriam Cavero; Bruno Aouizerate; Martin Schaefer; Lucile Capuron; J Javier Meana; Rocio Martin-Santos
Journal:  Int J Neuropsychopharmacol       Date:  2022-06-21       Impact factor: 5.678

Review 10.  In Vivo Targeting of the Neurovascular Unit: Challenges and Advancements.

Authors:  Oandy Naranjo; Olivia Osborne; Silvia Torices; Michal Toborek
Journal:  Cell Mol Neurobiol       Date:  2021-06-04       Impact factor: 4.231

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.